Vincent Jullien

Vincent Jullien is an experienced professional in the field of pharmacovigilance with a comprehensive background in managing global PV systems across various sectors, including pharmaceuticals, medical devices, and cosmetics. Currently serving as the Head of Global Pharmacovigilance at Galderma since December 2016, Vincent defines and oversees the PV vision and strategy, ensuring compliance with regulatory standards and continuous assessment of product safety profiles. Previous roles at Galderma included Director of Global Head Pharmacovigilance Operational Excellence and Global Director Pharmacovigilance & EU QPPV. Before joining Galderma, Vincent held leadership positions at Guerbet and Takeda, focusing on corporate pharmacovigilance management and quality assurance. Vincent holds a PharmD and multiple master's degrees related to pharmacovigilance, pharmacology, and biostatistics from Université Paris Cité.